The endocrine pancreas in non-diabetic rats after short-term and long-term treatment with the long-acting GLP-1 derivative NN2211.
about
Mechanisms of action of glucagon-like peptide 1 in the pancreasPreclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor AgonistsThe human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes.Effects of the glucagon-like peptide-1 receptor agonist liraglutide in juvenile transgenic pigs modeling a pre-diabetic conditionThe GLP-1 system as a therapeutic target.Liraglutide: a once-daily GLP-1 analogue for the treatment of type 2 diabetes mellitus.Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors.Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation.Incretin-based therapies: review of the outpatient literature with implications for use in the hospital and after discharge.Non-glycaemic effects mediated via GLP-1 receptor agonists and the potential for exploiting these for therapeutic benefit: focus on liraglutide.Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.Liraglutide Compromises Pancreatic β Cell Function in a Humanized Mouse Model.Systemic and acute administration of parathyroid hormone-related peptide(1-36) stimulates endogenous beta cell proliferation while preserving function in adult mice.Taspoglutide, a novel human once-weekly GLP-1 analogue, protects pancreatic β-cells in vitro and preserves islet structure and function in the Zucker diabetic fatty rat in vivo.Role of glucagon-like peptide-1 analogues on insulin receptor regulation in diabetic rat hearts.Liraglutide: a once-daily human glucagon-like peptide-1 analogue.Impact of incretin therapy on islet dysfunction: an underlying defect in the pathophysiology of type 2 diabetes.Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus.Pancreatic safety of GLP-1-based therapeutic agents: further insights from rodent studies?Glucagon-like peptide-1 receptor agonist treatment reduces beta cell mass in normoglycaemic mice.GLP-1: target for a new class of antidiabetic agents?
P2860
Q24683764-91D64150-12C5-4CFE-9822-61EBF5DA530BQ33521451-E2D0FEF0-F765-4C25-977D-BEB53695B77BQ33826388-0871777F-2F07-4287-AEF1-890096E7FA7FQ35184904-BE7730DA-3FD1-47DA-B460-A36B7EF001B3Q36265221-6E751120-7890-4DE9-A9D1-11DC26C3F936Q36715772-26FC667D-BEE0-42CD-8FA9-7D99331B227FQ37270524-92F4CC2C-F739-469D-9EB1-6B15D4A26490Q37635255-F09ED560-FE71-48DE-94A2-4E43DA195BC2Q37780914-94FF11E5-7739-4696-91F4-DFA8A75A388AQ37992259-12528E70-F0FB-4B88-946D-8E5BE6FA23E3Q38254745-D86E825A-9929-4D95-B9A2-6CD45855EAB9Q38884947-C49924C7-2D85-4791-8218-245363313C81Q39723419-48187082-F830-4024-ABEB-30FA9C3C216BQ42482084-F645A9C0-0C40-4BC7-BCE8-DD80FA8B0243Q43174358-7C1221E5-E828-4920-8C67-AE3B6673BFE7Q43234814-F58BEA34-ECB9-4BC3-B8AA-5E4F74BF9A5EQ46140543-0B4A8C25-C583-49FF-8E8B-C105FAF3B7DCQ46804042-F05A0232-D14A-40AB-B7ED-B55DC5C75DCDQ50862636-05B09901-6C1F-4F48-8337-8A2685B47AC2Q50903830-90FDF9C7-6F2E-4C78-8CC4-1FAEBF6BDDB8Q55116155-C1AFBEB8-5815-41CE-A94E-A3A83176A1CE
P2860
The endocrine pancreas in non-diabetic rats after short-term and long-term treatment with the long-acting GLP-1 derivative NN2211.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
The endocrine pancreas in non- ...... cting GLP-1 derivative NN2211.
@en
The endocrine pancreas in non- ...... cting GLP-1 derivative NN2211.
@nl
type
label
The endocrine pancreas in non- ...... cting GLP-1 derivative NN2211.
@en
The endocrine pancreas in non- ...... cting GLP-1 derivative NN2211.
@nl
prefLabel
The endocrine pancreas in non- ...... cting GLP-1 derivative NN2211.
@en
The endocrine pancreas in non- ...... cting GLP-1 derivative NN2211.
@nl
P2860
P1476
The endocrine pancreas in non- ...... cting GLP-1 derivative NN2211.
@en
P2093
Troels Bock
P2860
P304
P356
10.1111/J.1600-0463.2003.APM1111207.X
P577
2003-12-01T00:00:00Z